Embecta (EMBC) | Stock Overview & Key Data

Embecta Corporation | Small-cap | Healthcare

$10.04

5.02%

| Embecta Stock Comparison:

Embecta vs Intuitive Surgical Embecta vs Becton, Dickinson Embecta vs Lemaitre Vascular Embecta vs AtriCure Embecta vs Azenta Embecta vs S&P 500 | Market

Chart Range Statistics Financials Returns Ownership Calculator FAQ

Embecta Performance Comparison

Loading chart data...

Embecta

Healthcare Sector

S&P 500

View Full Price History

Stock Range

Today's Range

Low: $9.49 High: $10.04

on June 16, 2025

52 Week Range

Low: $9.49 High: $21.48

on June 16, 2025

on December 2, 2024

All-Time High: $49.00 on March 21, 2022

Explore how other US stocks compare to their 52-week ranges: View US Market 52-Week Insights

Key Statistics

Market Cap i $558.7M

EPS i 0.89

P/E Ratio (TTM) i 10.74

Forward P/E i 4.21

P/B Ratio i -0.76

PEG Ratio i 4.21

Div. Yield i 6.28%

ROE i -10.61%

Beta i 1.077

Debt to Equity i -2.13

Financial Highlights

Profitability

Gross Margin i 63.36%

Operating Margin i 30.35%

Profit Margin i 4.89%

Returns and Earnings

Return on Assets (TTM) i 2.53%

Return on Equity (TTM) i -10.61%

EBITDA i $227.1M

Net Income (TTM) i $52.8M

Growth

Revenue (TTM) i

Revenue Per Share (TTM) i

Quarterly Revenue Growth i

Quarterly Earnings Growth i

Peer Performance Comparison

Company	Market Cap	1W	1M	3M	6M	YTD	1Y	3Y	5Y
Embecta EMBC	558.71M Small-cap	-2.35%	-23.52%	-26.46%	-51.00%	-52.79%	-25.31%	-66.17%	-77.77%
Intuitive Surgical ISRG	183.57B Large-cap	-8.06%	-9.18%	7.42%	-5.08%	-2.26%	20.29%	166.65%	161.53%
Becton, Dickinson BDX	49.36B Large-cap	-0.71%	-1.79%	-22.70%	-23.65%	-23.97%	-26.32%	-26.82%	-25.71%
Lemaitre Vascular LMAT	1.83B Small-cap	-3.57%	-2.58%	2.93%	-19.43%	-11.30%	1.30%	91.75%	235.39%
AtriCure ATRC	1.57B Small-cap	-9.50%	0.44%	-3.48%	-0.16%	4.01%	52.31%	-12.72%	-29.04%
Azenta AZTA	1.40B Small-cap	6.43%	9.68%	-16.30%	-31.89%	-38.85%	-43.24%	-55.44%	-28.00%

Ownership & Short Interest

Insider Ownership i 0.47%

Institutional Ownership i 101.48%

Shares Short i 3M

Short Ratio i 4.27

Short % of Shares Outstanding i 6.55%

Average 10-Day Volume i 642K

Average 90-Day Volume i 661K

Embecta Recurring Investment / Dollar-Cost Averaging Calculator

Calculate how a regular investment in Embecta would have performed over time.

Investment Amount

Investment Frequency

Start Date

End Date (Optional)

If not specified, the latest available data will be used

Reinvest Dividends

Note: This calculator is for informational purposes only and does not consider taxes, fees, or other costs associated with investing.

Frequently Asked Questions

What is EMBC's 52-week high and low?

In the last 52 weeks, Embecta reached a high of $21.48 (on December 2, 2024) and a low of $9.49 (on June 16, 2025).

What is the market cap and P/E ratio for EMBC?

Curious about Embecta's size and valuation? Its market capitalization stands at 558.71M. When it comes to valuation, the P/E ratio (trailing twelve months) is 10.74, and the forward P/E (looking ahead) is 4.21.

Does EMBC pay dividends? If so, what's the yield?

Yes, Embecta is a dividend-paying stock. Investors have recently enjoyed a trailing annual dividend yield of 6.28%, and the company is expected to pay out $0.60 per share over the coming year.

Who are Embecta's main competitors or similar companies to consider before investing?

When looking at Embecta, it can be helpful to see how it compares to other players in its field. Here are a few similar companies or key competitors:

Company	Mkt Cap	Sector	Industry	1Y Return	3Y Return
Intuitive Surgical ISRG	183.57B	Healthcare	Medical Instruments & Supplies	20.29%	166.65%
Becton, Dickinson BDX	49.36B	Healthcare	Medical Instruments & Supplies	-26.32%	-26.82%
Lemaitre Vascular LMAT	1.83B	Healthcare	Medical Instruments & Supplies	1.30%	91.75%
AtriCure ATRC	1.57B	Healthcare	Medical Instruments & Supplies	52.31%	-12.72%
Azenta AZTA	1.40B	Healthcare	Medical Instruments & Supplies	-43.24%	-55.44%

For a more comprehensive list, please see the Peer Performance Comparison table on this page.

What are the key financial health indicators for Embecta Corporation? (e.g., ROE, Debt/Equity)

To get a sense of Embecta's financial health, here are a few key indicators: its Return on Equity (ROE) over the last twelve months is -10.61%, the Debt to Equity ratio from the most recent quarter is -2.13, and its Gross Profit Margin stands at 63.36%.

What is the recent revenue and earnings growth for EMBC?

Looking at Embecta's growth, its revenue over the trailing twelve months (TTM) was $1B. Compared to the same quarter last year (YoY), quarterly revenue grew by -9.80%, and quarterly earnings saw a YoY growth of -18.70%.

How much of EMBC stock is held by insiders and institutions?

Wondering who owns Embecta stock? Company insiders (like executives and directors) hold about 0.47% of the shares, while institutional investors (such as mutual funds and pension funds) own approximately 101.48%.

For more common questions about our data, please visit our About Data page.

Data is provided for informational purposes only. Devyara does not guarantee the accuracy of the data displayed.